HLB CEO Jin Yang-gon Confident in Competing with Roche and Strong Shareholder Returns
Jin Yang-gon “Our competitor is Roche, and shareholder returns are strong”” height=”300″ src=”width=”600″ /> ▲ HLB CEO Jin Yang-gon spoke to shareholders at a shareholder meeting after the general shareholders’ meeting on the 29th, answering questions. [세종특별자치시=비즈니스포스트] “Time will be the judge.” HLB CEO Jin Yang-gon said at a shareholder meeting held after the general […]
‘History of Korean clinical trials’ Korea Clinical Development Research Association “We will become a spokesperson for the clinical-related industry”
Yoonhee Lim, 8th President of the Korea Clinical Development Research Association 1999. This is the year that Korea began global clinical trials in earnest. At the center of clinical trials in Korea, which has grown rapidly in about 25 years, is the Korea Clinical Development Research Association. The Korea Clinical Development Research Association has changed […]
Gantenerumab: Disappointing Results from Phase 3 Clinical Trial for Alzheimer’s Disease
Gantenerumab’s Potential for Alzheimer’s Disease Disappoints in Final Clinical Evaluation Global pharmaceutical company Roche has unveiled the results of the final clinical evaluation of its new drug, gantenerumab, designed to treat Alzheimer’s disease. The findings, published in the prestigious New England Journal of Medicine, paint a disappointing picture of the drug’s efficacy in improving the […]
Retevmo LIBRETTO-431 Clinical Trial Data Reveals Significantly Improved Outcomes in Lung Cancer Treatment
LIBRETTO-431 Clinical Trial Data Shows Positive Results for Retevmo Treatment In a significant breakthrough for cancer treatment, the results of the phase 3 clinical trial for Retevmo (ingredient name: selpercatinib) were unveiled at the European Society of Medical Oncology (ESMO) conference. The trial, known as LIBRETTO-431, focused on patients with advanced or metastatic RET fusion […]
Digital Pathology: Revolutionizing Cancer Management in Korea
Digital Pathology in Korea: Experts Discuss Ways to Advance Cancer Management On July 19th, an important policy meeting took place at Lunit headquarters in Seoul’s Gangnam-gu district. The meeting, titled ‘Digital pathology, leading in cancer management in Korea,’ brought together academics and industry professionals to discuss strategies for revitalizing digital pathology in the country. Reporter […]
Is a cancer vaccine commercially available?
Image Source: Getty Image Bank [메디칼업저버 양영구 기자] The commercialization of the ‘cancer vaccine’ being developed by the global pharmaceutical industry is getting closer. Currently, cervical cancer is the only vaccine that can prevent cancer. Cervical cancer is caused by human papillomavirus (HPV) infection, so targeting it can prevent cancer. However, since vaccines are innately […]
pushing for access to treatment rights improving quality of life ‘Patient with liver cancer’
Key Point : WHO says it is the number 1 most common cancer in Thailand in 2020 liver cancer 14.4% of 27,384 cases, and Thailand ranks 4th in the world with a high death rate from liver cancer. However, treating liver cancer still has a place because despite this other cancer patients have fair access […]
